Request a Quote Ask a specialist
Radium-223 dichloride is an alpha particle-emitting radiotherapy drug that mimics calcium and forms complexes with hydroxyapatite at areas of increased bone turnover. The principal use of radium-223, as a radiopharmaceutical to treat metastatic cancers in bone, takes advantage of its chemical similarity to calcium, and the short-range of the alpha radiation it emits.
2 fields · 1 populated
On request Radiochemical purity
Ask a specialistt½ 11.4 days
Final activity mCi
A = A₀ · ½^(t / 11.4 days). Indicative only — confirm calibration with the order desk.
Shipped in Type A packaging with regional licensing handled.
Calibrated to your delivery date, shipped from qualified reactor and cGMP partners.
DMF assistance and documentation for Canada, USA and Latin America filings.
Type A packaging, licensing and customs handled by our regional order desks.
Ask me anything about our products, services or company. I answer from this website.
Answers come from this website and may not be complete. Conversations are stored so we can improve them.
